Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar valueable (43.23) Submitted: 6/24/2012 7:37:14 PM : Outperform Start Price: $48.57 JAZZ Score: +1.65

Jazz Pharmaceuticals is a great business with a great balance sheet. If a company can pay off all its debt (Jazz doesn't have any debt) and its total liability with just the cash it has on hand i don't know about you but to me that company has great balance sheet.

Featured Broker Partners


Advertisement